Evidence map›Paper›PMID 38478110›Full record

ArticleAnalytical and bioanalytical chemistry2024

The 2023 Nobel Prize in Chemistry: Quantum dots.

K David Wegner, Ute Resch-Genger

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Synthesis of Environmentally Friendly Heavy-Metal-Free AgInSMethods in molecular biology (Clifton, N.J.) · 2026
    Article
  5. Review
  6. Synthesis of AgInSDiscover oncology · 2025
    Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

K David WegnerDivision Biophotonics, Federal Institute for Materials Research and Testing (BAM), Richard-Willstaetter-Straße 11, Berlin, 12489, Germany.
Ute Resch-GengerDivision Biophotonics, Federal Institute for Materials Research and Testing (BAM), Richard-Willstaetter-Straße 11, Berlin, 12489, Germany. ute.resch@bam.de.ORCID http://orcid.org/0000-0002-0944-1115

Funding

Deutsche Forschungsgemeinschaft DFG-ANR grant SIREN (DFG RE1203/38-1)
6 · The paper itself

Abstract

The 2023 Nobel Prize in Chemistry was awarded to Aleksey I. Ekimov (prize share 1/3), Louis E. Brus (prize share 1/3), and Moungi G. Bawendi (prize share 1/3) for groundbreaking inventions in the field of nanotechnology, i.e., for the discovery and synthesis of semiconductor nanocrystals, also termed quantum dots, that exhibit size-dependent physicochemical properties enabled by quantum size effects. This feature article summarizes the main milestones of the discoveries and developments of quantum dots that paved the road to their versatile applications in solid-state lighting, display technology, energy conversion, medical diagnostics, bioimaging, and image-guided surgery.

Indexed as

BioimagingBiosensingPhotocatalysisPhotovoltaicsQuantum dotSynthesis

Identifiers

PMID38478110
PMCPMC11106203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.